Skip to main content
. 2022 Oct 17;11:72. doi: 10.1186/s40164-022-00323-9

Fig. 3.

Fig. 3

Long-term outcome of patients. A. Duration time of remission after ASCT following CAR30 T-Cell infusion. The red column represents complete response (CR) and the blue column represents partial response (PR). Arrow indicates ongoing response. B, C. Propability of PFS (B) or OS (C) of enrolled patients after ASCT following CAR30 T-Cell infusion. Tick marks represent censored data. P patient